McKesson Corporation (MCK) keeps making waves in the healthcare sector. The corporation recently announced a 15% rise in quarterly dividend to $0.82 per share. This was one of the key decisions made during the Annual Shareholder Meeting. Despite market fluctuations, MCK is attracting investor attention. It is regarded as a trending stock due to its solid growth and value. Wall Street analysts hold bullish opinions on the stock's potential. Morgan Stanley hiked its MCK price target, affirming the stock's earnings growth prospects. Additionally, Wells Fargo confirms a $766 price target based on its performance. The company's earnings have been growing consistently and have topped Wall Street estimates. Meanwhile, in strategic moves, McKesson plans to spin-off its medical-surgical solutions business. The company also recently acquired PRISM Vision Holdings for $850 million to strengthen its position in ophthalmology leadership. McKesson's stock has been rallying, hitting all-time highs despite occasional dips. These solid financials underscore its resilience and potential for continuous growth. Shareholders remain extremely optimistic.
Mckesson Corporation MCK News Analytics from Mon, 04 Nov 2024 08:00:00 GMT to Fri, 01 Aug 2025 14:29:56 GMT -
Rating 7
- Innovation 6
- Rumor 1
